Table 1.
Comparison of demographics and clinical outcomes of pediatric patients with MSSA Infection stratified by the origin of infections
| Characteristics | CA (n = 94) No. (%) |
HA (n = 37) No. (%) |
P value | HA | |
|---|---|---|---|---|---|
| CO (n = 17) No. (%) |
HO (n = 20) No. (%) |
||||
| Demographics | |||||
| Age in month median, IQR) | 67.5 (22.3–165) | 15 (4–156) | 66 (5.5–168.5) | 6 (3–75) | |
| Male sex (male%) | 63 (67) | 21 (56.8) | 0.270 | 10 (58.8) | 11 (55) |
| Underlying Diseases | |||||
| None (%) | 61 (46.6) | 15 (40.5) | 0.011 | 6 (35.3) | 9 (45) |
| Atopic syndrome (%) | 14 (10.7) | 1 (2.7) | 0.049 | 0 (0) | 1 (5) |
| Preterm (%) | 0 (0) | 7 (18.9) | 0 | 0 (0) | 7 (35) |
| Immunodeficiency (%) | 0 (0) | 1 (2.7) | 0.110 | 1 (5.9) | 0 (0) |
| Renal Diseases (%) | 1 (1) | 1 (2.7) | 0.491 | 1 (5.9) | 0 (0) |
| Urogenital problems (%) | 0 (0) | 2 (5.4) | 0.023 | 1 (5.9) | 1 (5) |
| Gastrointestinal problems (%) | 0 (0) | 1 (2.7) | 0.110 | 0 (0) | 1 (5) |
| Cardiovascular diseases (%) | 1 (1) | 1 (2.7) | 0.491 | 1 (5.9) | 0 (0) |
| Malignancies and Hematologic Diseases (%) | 0 (0) | 2 (5.4) | 0.023 | 1 (5.9) | 1 (5) |
| Metabolic Diseases (%) | 2 (1.5) | 1 (2.7) | 0.843 | 0 (0) | 1 (5) |
| Neurological Diseases (%) | 5 (3.8) | 7 (18.9) | 0.015 | 7 (41.2) | 0 (0) |
| ENT anomaly (%) | 12 (9.2) | 3 (8.1) | 0.451 | 3 (17.6) | 0 (0) |
| Inpatient (%) | 29 (22.1) | 31 (83.8) | 0 | 11 (64.7) | 20 (100) |
| Outcome | |||||
| Septic shock (%) | 1 (0.8) | 0 (0) | |||
| Attributable mortality (%) | 0 (0) | 0 (0) | |||
| Non-attributable mortality (%) | 0 (0) | 3 (8.1) | |||
| Recurrent infection (%) | 3 (2.3) | 0 (0) | |||
| Uneventfully (%) | 88 (93.6) | 34 (91.9) | |||
CA community-associated, HA healthcare-associated, CO community onset, HO hospital onset